Successful Resection After Neoadjuvant Therapy in Pancreatic Adenocarcinoma

被引:1
|
作者
Peddi, Parvin F. [1 ]
Wang-Gillam, Andrea [1 ]
机构
[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63110 USA
关键词
PHASE-II; CANCER; CHEMORADIOTHERAPY; CHEMOTHERAPY; 5-FLUOROURACIL; GEMCITABINE; SURVIVAL; IMPACT; TRIAL;
D O I
10.6004/jnccn.2012.0139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 59-year-old woman presented with borderline resectable pancreatic adenocarcinoma involving the neck and body of the pancreas. She was treated with systemic chemotherapy followed by chemoradiation, with subsequent downstaging of the tumor by imaging. Subsequent resection had negative margins and negative lymph nodes with only microscopic disease present in the tumor specimen. Neoadjuvant therapy is controversial but could play a role in borderline resectable disease by allowing for higher chance of negative margins at surgery and increasing the chance for cure in these patients. Microscopic disease at time of resection is rare. (JNCCN 2012;10:1330-1334)
引用
收藏
页码:1330 / 1334
页数:5
相关论文
共 50 条
  • [41] Effect of Neoadjuvant Chemotherapy on Postoperative Morbidity after Pancreatic Resection for Pancreatic Adenocarcinoma: An American College of Surgeons NSQIP Analysis
    Picado, Omar
    Brosch, Jessica R.
    Rubio, Gustavo A.
    Yakoub, Danny
    Franceschi, Dido
    Sleeman, Danny
    Livingstone, Alan S.
    Merchant, Nipun B.
    Dudeja, Vikas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E46 - E46
  • [42] Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy
    Sohei Satoi
    Hiroaki Yanagimoto
    Tomohisa Yamamoto
    Chisato Ohe
    Chika Miyasaka
    Yoshiko Uemura
    Satoshi Hirooka
    So Yamaki
    Hironori Ryota
    Taku Michiura
    Kentaro Inoue
    Yoichi Matsui
    Noboru Tanigawa
    Masanori Kon
    Surgery Today, 2017, 47 : 84 - 91
  • [43] Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
    Wilson Luiz da Costa
    Hop S. Tran Cao
    Kyle H. Sheetz
    Xiangjun Gu
    Edward C. Norton
    Nader N. Massarweh
    Annals of Surgical Oncology, 2021, 28 : 3186 - 3195
  • [44] NEOADJUVANT THERAPY AND 30-DAY POSTOPERATIVE OUTCOMES AMONG PATIENTS UNDERGOING RESECTION FOR PANCREATIC ADENOCARCINOMA
    Dennis, Samuel O.
    Irish, William
    Parikh, Alexander
    Snyder, Rebecca A.
    GASTROENTEROLOGY, 2020, 158 (06) : S1581 - S1581
  • [45] Trends from NSQIP 2015 to 2017 in neoadjuvant therapy use before pancreatic adenocarcinoma resection.
    Gologorsky, Rebecca C.
    Ely, Sora
    Dominguez, Dana
    Huyser, Michelle
    Chang, C. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
    da Costa, Wilson Luiz, Jr.
    Tran Cao, Hop S.
    Sheetz, Kyle H.
    Gu, Xiangjun
    Norton, Edward C.
    Massarweh, Nader N.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3186 - 3195
  • [47] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [48] Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?
    Chopra, Asmita
    Paniccia, Alessandro
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 728 - 730
  • [49] Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy
    Satoi, Sohei
    Yanagimoto, Hiroaki
    Yamamoto, Tomohisa
    Ohe, Chisato
    Miyasaka, Chika
    Uemura, Yoshiko
    Hirooka, Satoshi
    Yamaki, So
    Ryota, Hironori
    Michiura, Taku
    Inoue, Kentaro
    Matsui, Yoichi
    Tanigawa, Noboru
    Kon, Masanori
    SURGERY TODAY, 2017, 47 (01) : 84 - 91
  • [50] Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (06) : 1432 - 1440